Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studyShaji Kumar, B G M Durie, Meletios Α. Dimopoulos et al.|Leukemia|2017Cited by 356
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibodyWei Wang, Saburo Sone, Yasuhiko Nishioka et al.|Cancer Immunology Immunotherapy|2008Cited by 64
Concurrent Oral 4 - Basic Science [OP24-OP31]: OP24. Hdac Activity: A Therapeutic Target in Rheumatoid Arthritis?Justin Gillespie, Francesco Dell’Accio, Sinisa Savic et al.|Lara D. Veeken|2010Cited by 0
[Hemostatic therapy for hemorrhagic cholecystitis in a patient with hemophilia A with inhibitors].Shuji Ozaki, Makiko Mizuguchi, Yasunobu Okamoto et al.|PubMed|2025Cited by 0